0

<< Management of Inflammatory Bowel Disease Flares in the Emergency Department (Pharmacology CME)

Etiology and Pathophysiology

IBD pathogenesis is multifactorial and involves variations in the patient’s genome, environmental factors, and alterations in the intestinal microbiota and the mucosal immune response. The microbiota of people with IBD tends to be less rich and less diverse than in those without IBD. Additionally, in people with IBD, intestinal mucus is thinner and has an altered composition, which leads to a compromised barrier and subsequently increased intestinal permeability. The interplay of these factors, in addition to other environmental triggers, culminates in a dysregulated immune response, involving both innate and adaptive responses, ultimately leading to intestinal inflammation.6,7 Of note, the adaptive immune response produces an immunoglobulin G (IgG) antibody against an epithelial antigen of the colon that is also found in the skin, eyes, joints, and biliary tract and likely plays a role in extraintestinal manifestations of IBD.8 While much of the exact nature of its pathophysiology is unknown, several key risk factors for IBD have been identified:

  • Genetic susceptibility: As of 2015, 163 IBD-associated gene variants had been discovered. The risk for developing IBD has a positive correlation with gene number; however, gene presence alone accounts for approximately 25% of IBD cases, suggesting that the manifestation of IBD is influenced by the interaction of these genes with each other or with environmental factors.7
  • Ethnicity: White Northern European and North American populations have the highest IBD prevalence. The lowest prevalence is found in the populations of continental Asia.8
  • Infection: Gastrointestinal infections confer an increased risk for IBD development, particularly acute gastroenteritis caused by Salmonella, Campylobacter, and Shigella.9,10 Although the risk is highest in the year following infection, a 2009 cohort study showed that exposed subjects had an elevated risk throughout the 15-year study period.10
  • Environment: A variety of environmental factors have been linked to IBD, particularly those that correspond to a Westernized environment and lifestyle. Of these, smoking, gut microbiota, diet (high-fat, high-sugar), and medications (early and frequent antibiotic exposure in the first years of life) have the strongest supporting evidence for links to IBD.7,8

Crohn Disease

CD causes full-thickness, transmural inflammation of the intestinal wall. Although CD can affect any portion of the gastrointestinal tract, from the mouth to the anus, approximately 70% percent of patients will have some degree of terminal ileal disease. In approximately 55% of CD patients, inflammation involves both the colon and terminal ileum. Isolated terminal ileal disease and isolated colon disease each account for approximately 15% of those with CD.11

Although the most common CD manifestations are chronic diarrhea, abdominal pain, and weight loss, due to the heterogeneity in disease phenotype, the presentation of a CD flare can vary significantly.8 Active small-bowel inflammation typically presents as an obstruction or ileus, with colicky abdominal pain, distension, nausea, or loose bowel movements.7 Hematochezia is often a sign that the colon is involved and is usually associated with diarrhea and muco-purulent discharge. Patients with perianal disease will present with perianal drainage and pain with sitting and defecating.12 The transmural nature of CD leads to the progression of penetrating disease and the formation of strictures, fistulas, and abscesses,13 complications that have the potential to become surgical emergencies. Additionally, small-bowel disease leads to malabsorption and vitamin deficiencies.

To continue reading, please log in or purchase access.

Already purchased this course?
Log in to read.
Purchase a subscription

Price: $449/year

140+ Credits!

Purchase Issue & CME Test

Price: $49

+4 Credits!

Money-back Guarantee
Get Quick-Read Evidence-Based Updates
Enter your email to get free evidence-based content delivered to your inbox once per month.
Please provide a valid email address.